Target intelligence / Profile preview

ATP synthase subunit c

Molecular classification
Enzyme (component of ATP synthase complex), Ion transporter, Rotary motor subunit of Fo/F1 ATP synthase
01

Overview

ATP synthase subunit c is a highly conserved, hydrophobic membrane protein forming the core of the Fo (mitochondrial) or Vo (vacuolar) rotary motor in ATP synthase complexes. It assembles into an oligomeric c-ring embedded in the inner mitochondrial membrane, facilitating proton translocation that powers ATP synthesis. The c-ring’s rotation, driven by proton gradients, is mechanically coupled to the catalytic F1 domain, enabling energy conversion. In humans, it is encoded by three nuclear genes, all producing an identical mature protein. Besides its physiological role, the c subunit is implicated in pathological mitochondrial membrane permeabilization, cell death, and certain lysosomal storage diseases. Its inhibition in pathogens serves as a target for antibiotics like bedaquiline, but non-selective inhibition poses a therapeutic risk due to potential systemic mitochondrial toxicity.

Other names
proteolipid subunit csubunit 916 kDa proteolipidATP5G1 (human gene)ATP5G2ATP5G3ATPase c subunitc subunit of Fo/Vo complex
02

Mechanism of action

Bedaquiline: binds to c-ring, inhibiting proton translocation and ATP synthesis in mycobacteria; DCCD: covalently modifies a key glutamate/aspartate in the c subunit, blocking proton translocation; Inhibitors of mitochondrial permeability transition: target c-ring’s role in pore formation, potentially preventing cell death.

03

Biological functions

ATP synthesis (oxidative phosphorylation)Proton translocation across membranesMaintenance of mitochondrial membrane potentialIon channel activity (implicated in mitochondrial permeability transition pore formation)
04

Disease associations

Neurodegenerative disease (implicated in Batten disease/ceroid-lipofuscinosis, due to abnormal accumulation)Mitochondrial dysfunction (in mitochondrial permeability transition)Other (possible broader roles in cell death and pathological calcium signaling)
05

Safety considerations

High conservation across species raises risk of mitochondrial toxicity or off-target effects for drugs developed against bacterial/fungal c subunitsInhibiting mammalian c subunit may disrupt essential ATP synthesis, leading to cellular energy failure and cell deathMisfolded/aggregated forms are amyloidogenic, potentially toxic in neurodegenerative disease contexts
06

Interacting drugs

Bedaquiline (inhibits c subunit in mycobacterial ATP synthase)

2 more in the full profile.

Beyond the preview

Go deeper on ATP synthase subunit c.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP synthase subunit c.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call